NICOBRAND LIMITED
Operating as a subsidiary of the German group Contraf-Nicotex-Tobacco GmbH, the business manufactures pharmaceutical preparations.
Get an alert when NICOBRAND LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£11m
+343.8% highest in 6 filed years
Net assets
£53m
+30.6% highest in 6 filed years
Employees
88
+35.4% highest in 6 filed years
Profit before tax
£26m
-3% vs 2024
Net assets
6-year trend · vs Health Care median
Accounts
6-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|---|
| Turnover | £8,115,060 | £17,229,440 | £16,137,402 | £28,677,726 | £66,268,530 | £62,492,781 | -5.7% | |
| Operating profit | £2,010,012 | £7,493,591 | £4,939,577 | £10,470,379 | £27,349,592 | £26,468,753 | -3.2% | |
| Profit before tax | £2,004,342 | £7,490,733 | £4,942,205 | £10,458,342 | £27,293,366 | £26,481,569 | -3% | |
| Net profit | £1,650,567 | £6,066,271 | £4,016,004 | £7,926,711 | £20,493,757 | £19,859,413 | -3.1% | |
| Cash | £776,572 | £6,307,611 | £2,139,628 | £2,919,085 | £2,491,541 | £11,058,475 | +343.8% | |
| Total assets less current liabilities | £8,564,087 | £14,691,285 | £16,704,090 | £22,963,063 | £41,198,402 | £53,698,817 | +30.3% | |
| Net assets | £8,336,703 | £14,402,974 | £16,429,460 | £22,623,971 | £40,593,678 | £53,014,191 | +30.6% | |
| Equity | £8,336,703 | £14,402,974 | £16,429,460 | £22,623,971 | £40,593,678 | £53,014,191 | +30.6% | |
| Average employees | 33 | 39 | 40 | 49 | 65 | 88 | +35.4% | |
| Wages | £1,314,911 | £1,513,084 | £1,445,498 | £1,852,964 | £2,431,177 | £3,594,854 | +47.9% | |
| Directors' remuneration | £356,599 | £289,843 | £316,656 | £338,272 | £354,890 | £463,269 | +30.5% | |
| Directors' pension contributions | — | — | — | £10,032 | £32,054 | £11,569 | -63.9% | |
| Highest paid director | — | — | — | £198,903 | £208,419 | £264,870 | +27.1% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | 24.8% | 43.5% | 30.6% | 36.5% | 41.3% | 42.4% | |
| Net margin | 20.3% | 35.2% | 24.9% | 27.6% | 30.9% | 31.8% | |
| Return on capital employed | 23.5% | 51.0% | 29.6% | 45.6% | 66.4% | 49.3% | |
| Gearing (liabilities / total assets) | 15.2% | 12.1% | 19.3% | 14.7% | 13.3% | 6.9% | |
| Current ratio | — | — | — | 5.62x | 7.01x | 14.79x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- NICOBRAND LIMITED 1998-01-28 → present
- CAVATINA ENTERPRISES LIMITED 1997-11-19 → 1998-01-28
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Moore (N.I.) LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting”
Significant events
- “Dividends paid of £7,438,900 during 2025.”
- “Capital expenditure additions of £2,904,047 in tangible fixed assets.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BOYD, Helen Doreen | Secretary | 2016-01-19 | — | — |
| BOYD, Helen Doreen | Director | 2011-08-26 | May 1968 | British |
| MCQUILLAN, Mark | Director | 2011-08-26 | Aug 1976 | Irish |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BUCHEN, David | Secretary | 1997-11-19 | 2016-01-19 |
| PINSENT MASONS SECRETARIAL LIMITED | Corporate Secretary | 2017-03-13 | 2017-03-13 |
| BISARO, Paul Mino | Director | 2008-01-01 | 2011-08-30 |
| BUCHEN, David Adam | Director | 2002-05-10 | 2016-01-19 |
| CHAO (DR), Allen | Director | 1998-07-10 | 2008-01-01 |
| COOPER, Dean Michael | Director | 2018-07-12 | 2019-07-30 |
| HUMPHREY, John Alexander | Director | 1997-11-19 | 2011-08-30 |
| LAWRENCE, David | Director | 1998-07-10 | 2002-08-16 |
| MORROD, Ronald Jeffrey | Director | 2011-09-06 | 2014-03-31 |
| STEWART, Robert | Director | 2011-08-30 | 2016-08-02 |
| WILLIAMS, Robert | Director | 2016-08-02 | 2018-06-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Contraf -Nicotex-Tobacco Gmbh | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-07-01 | Active |
| Teva Pharmaceutical Industries Limited | Corporate entity | Shares 75–100%, Voting 75–100% (as firm), Appoints directors | 2016-08-02 | Ceased 2019-06-28 |
Filing timeline
Last 20 of 115 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-25 | AA | accounts | Accounts with accounts type full | |
| 2025-12-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-03 | AA | accounts | Accounts with accounts type full | |
| 2024-11-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-09 | AA | accounts | Accounts with accounts type full | |
| 2023-12-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-01 | AA | accounts | Accounts with accounts type full | |
| 2022-11-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-04-12 | AA | accounts | Accounts with accounts type full | |
| 2022-01-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-03-08 | AA | accounts | Accounts with accounts type full | |
| 2020-11-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-03-02 | AA | accounts | Accounts with accounts type full | |
| 2019-11-27 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2019-11-20 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2019-09-09 | CH01 | officers | Change person director company with change date | |
| 2019-07-30 | TM01 | officers | Termination director company with name termination date | |
| 2019-07-29 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2019-07-29 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2019-03-15 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.